FIELD: organic chemistry, pharmacy.
SUBSTANCE: invention proposes a method for treatment of bipolar disorder in mammal. Method involves administration of 1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxyphenyl]ethanone (iloperidone) or its pharmaceutically acceptable acid-additive salt in the therapeutically effective dosage. Invention provides treatment both psychosis and promoted to relief of state in leaving society that represents the main feature of depression. Standard doses of proposed agent comprise from 0.1 to 25 mg of compound.
EFFECT: improved method of treatment, valuable medicinal property of agent.
